Skip to main content

Advertisement

Log in

Referral patterns of patients with liver metastases due to colorectal cancer for resection

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Introduction

Colorectal carcinoma accounts for 10% of cancer deaths in the Western World, with the liver being the most common site of distant metastases. Resection of liver metastases is the treatment of choice, with a 5-year survival rate of 35%. However, only 5–10% of patients are suitable for resection at presentation.

Aims

To examine the referral pattern of patients with liver metastases to a specialist hepatic unit for resection.

Methodology

Retrospective review of patient’s charts diagnosed with colorectal liver metastases over a 10-year period.

Results

One hundred nine (38 women, 71 men) patients with liver metastases were included, mean age 61 years; 79 and 30 patients had synchronous and metachronus metastases, respectively. Ten criteria for referral were identified; the referral rate was 8.25%, with a resection rate of 0.9%. Forty two percent of the patients had palliative chemotherapy; 42% had symptomatic treatment.

Conclusion

This study highlights the advanced stage of colorectal cancer at presentation; in light of modern evidence-based, centre-oriented therapy of liver metastasis, we conclude that criteria of referral for resection should be based on the availability of treatment modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1271–1280

    Article  PubMed  Google Scholar 

  2. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262

    Article  PubMed  CAS  Google Scholar 

  3. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–825

    Article  PubMed  Google Scholar 

  4. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766

    Article  PubMed  Google Scholar 

  5. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438–447

    Article  PubMed  Google Scholar 

  6. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722

    Article  PubMed  Google Scholar 

  7. Alberts SR, Horvath WL, Sternfeld WC et al (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23:9243–9249

    Article  PubMed  CAS  Google Scholar 

  8. Ballantyne GH, Quin J (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71:4252–4266

    Article  PubMed  CAS  Google Scholar 

  9. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246

    Article  PubMed  CAS  Google Scholar 

  10. Ruers TJ, Bleichrodt RP (2002) Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38:1023–1033

    Article  PubMed  CAS  Google Scholar 

  11. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938–946

    PubMed  CAS  Google Scholar 

  12. Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19:59–71

    Article  PubMed  CAS  Google Scholar 

  13. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C (1996) Patient selection for hepatic resection of colorectal metastases. Arch Surg 131:322–329

    PubMed  CAS  Google Scholar 

  14. Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285–288

    PubMed  CAS  Google Scholar 

  15. Wanebo HJ, Semoglou C, Attiyeh F et al (1978) Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 135:81–86

    Article  PubMed  CAS  Google Scholar 

  16. Gennari L, Doci R, Bozzetti F, Bignami P (1978) Proposal for staging liver metastases. Recent Results Cancer Res 1986 100:80–84

    Google Scholar 

  17. Faivre J, Rat P, Arveux P, Nordlinger B, Jaeck D (1992) Epidémiologie des métastases hépatiques des cancers de colon. In: Traitement des Métastases Hépatiques des Cancers Colorectaux (94e Congrès Français de Chirurgie). Springer, Paris, pp 2–9

  18. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

    Article  PubMed  CAS  Google Scholar 

  19. Maurel J, Pottier D, Grosclaude P, Tretare B, Arveux P, Raverdy N et al (1998) Therapeutic management of colonic cancer in France. Gastroenterology Clin Biol 22(Suppl 3):S90–S96

    CAS  Google Scholar 

  20. de Jong KP (2007) Review article: multimodality treatment of liver metastases increases suitability for surgical treatment. Aliment Pharmacol Ther 26(s2):s161–169

    Article  Google Scholar 

  21. Ruers TJ, de Jong KP, IJzermans JN (2005) Radiofrequency for the treatment of liver tumours. Dig Surg 22:245–253

    Article  PubMed  CAS  Google Scholar 

  22. Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ (2006) Radiofrequency ablation of liver tumours: a systematic review. Arch Surg 141:181–190

    Article  PubMed  Google Scholar 

  23. Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107:521–527

    PubMed  CAS  Google Scholar 

  24. Nordlinger B, Sorbye H, Collette L et al (2007) Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. ASCO Annual Meeting Proceedings. J Clin Oncol 25(18S):LBA5

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. Al-Sahaf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Sahaf, O., Al-Azawi, D., Al-Khudairy, A. et al. Referral patterns of patients with liver metastases due to colorectal cancer for resection. Int J Colorectal Dis 24, 79–82 (2009). https://doi.org/10.1007/s00384-008-0561-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-008-0561-6

Keywords

Navigation